Name: Startup Pitch Presentations ATMP
Start: 2026-09-30T11:30:00+0200
End: 2026-09-30T12:15:00+0200

Wednesday September 30, 2026 11:30 - 12:15 CEST

Meet innovative companies developing Advanced Therapy Medicinal Products, which are innovative drugs for human used based on genes, cells or tissue engineering.

Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2026.

Presenting companies:

Amets Biotechnology – Laia Trigueros Motos, CEO
Golden Gate Biotech - Jascha Blobel, CEO
Miramoon Pharma – Amalia Capilla, CEO
Nocturna Therapeutics – Miriam Corredor, CEO
Peaches S.l. – Francesca Sarno, CSO
Popcorn Therapeutics – Iker Ausejo Mauleon,COO
Tetraneuron SL – Ángel Lucio Pereira, CEO

Speakers

Laia Trigueros Motos

CEO, Amets Biotechnology

Solid track record in biomedical research and strategic leadership, resulting in impactful scientific solutions. Training in business management with the mission of guiding the clinical translation and international growth of Amets Biotechnology.

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech

Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →

Amalia Capilla

CEO, Miramoon Pharma

Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at... Read More →

Miriam Corredor Sánchez

CEO, Nocturna Therapeutics

Miriam Corredor is CEO of NoctuRNA Therapeutics, a biotech company developing novel circular RNA therapeutics for neurodegenerative, neuromuscular and infectious diseases. She holds a PhD in Medicinal Chemistry in neurodegenerative diseases and a Master’s in Business Innovation... Read More →

Francesca Sarno

CSO, Peaches S.L.

PhD in Biology with 15+ years of experience in translational oncology and advanced therapy development. Formerly involved in CNIO and hospital-based research, with 20+ scientific publications and experience coordinating European R&D projects. As Scientific Director at Peaches Biotech... Read More →

Iker Ausejo Mauleon

COO, Popcorn Therapeutics

Dr. Iker Ausejo Mauleon obtained his Ph.D. in applied medicine and biomedicine from the University of Navarra in 2023, complemented by international experience at the MD Anderson Cancer Center in Houston. Recognized as an emerging talent under 35 in Navarra, he has received 8 prestigious... Read More →

Ángel Lucio Pereira

CEO, Tetraneuron S.L.

Angel Lucio is the CEO of Tetraneuron, a Spanish biotech company, advancing gene therapy solutions for Alzheimer’s disease and other neurodegenerative diseases. After several years supporting the company as an advisor and board member, Angel now leads its next phase of growth, as... Read More →

Wednesday September 30, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event